PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quotes Pacific Biosciences of California, Inc. Börse Stuttgart
Equities
P09
US69404D1081
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.219 EUR | +10.80% |
|
-18.89% | -88.05% |
| 07-01 | Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2500 Growth Index | CI |
| 06-27 | PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry | MT |
Quotes 5-day view
Delayed Quote Börse Stuttgart| 27/06/2024 | 28/06/2024 | 01/07/2024 | 02/07/2024 | 03/07/2024 | |
|---|---|---|---|---|---|
| Last | 1.231 € | 1.2602 € | 1.136 € | 1.1002 € | 1.248 € |
| Volume | 3 000 | 0 | 4 000 | 0 | 0 |
| Change | -5.50% | +2.37% | -9.86% | -3.15% | +10.80% |
| Opening | 1.24 | 1.24 | 1.24 | 1.10 | 1.151 |
| High | 1.30 | 1.29 | 1.31 | 1.10 | 1.248 |
| Low | 1.23 | 1.24 | 1.14 | 1.10 | 1.151 |
Performance
| 1 week | -18.89% | ||
| Current month | -12.70% | ||
| 1 month | -36.38% | ||
| 3 months | -67.06% | ||
| 6 months | -87.64% | ||
| Current year | -88.05% | ||
| 1 year | -91.25% | ||
| 3 years | -96.10% | ||
| 5 years | -79.24% | ||
| 10 years | -76.01% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
348 615 541
Capitalization (USD)
348 615 541
Net sales (USD)
200 521 000
Free-Float
98.1 %
Free-Float capitalization (EUR)
369 152 478
Free-Float capitalization (USD)
341 978 795
Average Daily Capital Traded
0%
Highs and lows
1 week
1.10
1.31
1 month
1.101.88
3 years
1.1029.70
5 years
1.1044.80
10 years
1.1044.80
Indicators
Moving average 5 days
1.21
Moving average 20 days
1.55
Moving average 50 days
1.63
Moving average 100 days
2.72
Price spread / (MMA5)
-1.07%
Price spread / (MMA20)
+27.33%
Price spread / (MMA50)
+33.50%
Price spread / (MMA100)
+123.31%
STIM
RSI 9 days
19.37
RSI 14 days
26.40
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -86.76% | ||
| 2023 | +24.59% | ||
| 2022 | -58.49% | ||
| 2021 | -11.88% | ||
| 2020 | +339.13% | ||
| 2019 | -28.46% | ||
| 2018 | +189.38% | ||
| 2017 | -38.55% | ||
| 2016 | -70.16% | ||
| 2015 | +91.64% | ||
| 2014 | +70.50% | ||
| 2013 | +199.11% |
- Stock Market
- Equities
- PACB Stock
- P09 Stock
- Quotes Pacific Biosciences of California, Inc.
